Immunodiagnostics Market Size, Share, Growth Analysis, By Product(Instruments, Reagents & Consumables), By Application(Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases), By End User(Clinical Laboratories, Hospitals, Physician’s Offices, Others), By Region - Industry Forecast 2024-2031

Collaborations and acquisitions are projected to be popular strategies for immunodiagnostics companies looking to expand their business scope going forward. Investing in the development of novel immunodiagnostics products and instruments is also forecasted to create new opportunities for market players in the future. Investing in developing countries is projected to offer lucrative opportunities for immunodiagnostics providers in the long run.  

Immunodiagnostics Market Top Player’s Company Profiles

• Abbott (US) 
• Roche Diagnostics (Switzerland) 
• DiaSorin (Italy) 
• Danaher Corporation (US) 
• QIAGEN (Netherlands) 
• bioMérieux (France) 
• Thermo Fisher Scientific (US) 
• Quest Diagnostics (US)  
• Siemens Healthineers AG (Germany) 
• Bio-Rad Laboratories, Inc. (US) 
• Sysmex Corporation (Japan) 
• PerkinElmer, Inc. (US) 
• Agilent Technologies, Inc. (US) 
• Mindray Medical International Limited (China) 
• Grifols, S.A. (Spain) 
• Becton, Dickinson and Company (BD) (US) 
• Abcam plc (UK) 
• Merck KGaA (Germany) 
• Enzo Biochem, Inc. (US) 
• Bio-Techne Corporation (US) 
• Meso Scale Diagnostics, LLC. (US) 
• GenScript Biotech Corporation (China) 
• Myriad Genetics, Inc. (US)

Immunodiagnostics Market